Aug 2026· BioNanoScience· Vol 16· 0 citations· 189 references
TL;DR
This comprehensive review on Nanotechnology focuses on the entire spectrum of ovarian cancer management and recent advances in physicochemical properties, PK/BD, diagnostic biosensors, treatment modalities to reverse MDR, immunomodulation and personalized nanomedicine are summarized.
Overall, cancer nanomedicine has evolved from a simple drug-delivery concept into a multifunctional therapeutic platform integrating targeted therapy, molecular imaging, immunomodulation, gene therapy, and personalized medicine.
Fouzan Arif Mulla Mulla, M. Khan, Irfan Nizamuddin Mansuri Mansuri et al.· Journal of Pharmacology, Gen...· 0 citations
INTRODUCTION
Nanomedicine has changed the course of oncology through drug-delivery systems that improve efficacy while reducing systemic toxicity. PEGylated liposomes have specifically revolutionized cancer treatment by enhancing pharmacokinetics, stability, and tumor-selective deposition via the enhanced permeability...
Ashish Kumar, Md Moidul Islam, Moidul Islam Judder et al.· Recent Advances in Drug Deli...· 0 citations
Nanotechnology has emerged as a transformative frontier for detecting and treating various types of tumours more accurately. As a leading technology, nanotechnology assists in overcoming the issues linked with traditional antitumor drug systems. Nanocarriers (NCs) are colloidal systems developed for precise drug delive...
Shalu Tiwari, Abhijeet Ojha, A. Singh et al.· Journal of Drug Delivery and...· 0 citations
Background: Breast cancer remains the most common malignant tumor among women worldwide. Although conventional treatments including surgery, chemotherapy, and radiotherapy are effective, they are confronted with challenges such as tumor heterogeneity, systemic toxicity, and recurrence driven by drug resistance. To over...
Kai-Yan Su, Yan Li, Dong-Mei Zhang et al.· Pharmaceutics· 0 citations
Theranostic nanomedicine integrates diagnostic and therapeutic functions into a single nanoparticle, allowing clinicians to image a tumor and treat it with the same agent. The logic is simple: instead of administering separate compounds to patients for imaging and treatment, both functions are delivered concurrently. N...
B. E, Vivekanandan K, P. K. et al.· Mini-Reviews in Medical Chem...· 0 citations
A translational framework for overcoming key barriers in pharmaceutical intervention design for oncology applications is outlined, integrating drug delivery engineering, molecular biopharmaceutics, and computational optimization.
Manoj Dalabehera, Shubham K. Chaudhari, Jatin Kumar et al.· Journal of Pharmacy and Scie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.